We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Papers
2 resultsShowing papers from Asan Medical Center
ClearEmpirical antibiotics of non-carbapenems for ESBL-producing E. coli and K. pneumoniae bacteremia in children : a retrospective medical record review
Researchers retrospectively analyzed clinical outcomes for 53 pediatric patients with ESBL-producing E. coli and K. pneumoniae bacteremia treated with carbapenem or non-carbapenem empirical antibiotics between 2014 and 2019. They found a 30-day all-cause mortality rate of 17%, with 84.6% of non-carbapenem-treated patients switched to carbapenem therapy by day 2, suggesting non-carbapenem empirical therapy was frequently inadequate for this population.
Initial empirical antibiotics of non-carbapenems for ESBL-producing E. coli and K. pneumoniae bacteremia in children: a retrospective medical record review
Researchers reviewed medical records of children with bloodstream infections from antibiotic-resistant bacteria and found that starting with non-carbapenem antibiotics — a broader, less powerful class — did not increase mortality risk as long as treatment was quickly adjusted once lab results confirmed the specific bacteria involved.